Creative Biolabs is tackling persistent obstacles in bispecific antibody development by integrating artificial intelligence-driven design with proprietary engineering platforms, focusing on structural stability and manufacturing complexity. The company addresses the "chain pairing" challenge, where mispairing and low yields have hindered progress, through diverse custom formats including Knobs-in-Holes, CrossMab, and DVD-Ig. A Senior Scientist at Creative Biolabs emphasized that successful therapeutics depend not only on binding affinity but also on developability, noting that their platform ensures bispecific antibody products are optimized for high-purity purification and clinical scalability.
To support researchers, Creative Biolabs has compiled insights from technical data, highlighting methods to ensure correct heavy and light chain pairing. They use advanced technologies like Charge Pair and Orthogonal Fab interfaces to force correct assembly, achieving heterodimerization efficiency often exceeding 90%. For applications requiring blood-brain barrier penetration, specific fragments such as tandem scFvs or sdAb-based BsAbs are preferred due to their smaller size and better tissue penetration. The company's portfolio also extends to non-IgG formats, including bispecific immunotoxins, diabodies, and bispecific aptamers, catering to diverse research needs.
Client feedback underscores the impact of these services, with a lead researcher from a top-tier biopharmaceutical firm praising Creative Biolabs for facilitating a seamless transition from scFv screening to a fully functional IgG-scFv format. The analytical package, including SEC-MALS and PK/PD data, proved instrumental for regulatory filings like IND submissions. Beyond custom bsab development, Creative Biolabs offers an extensive catalog of off-the-shelf products targeting key markers such as CD3, HER2, and PD-1, each rigorously characterized through biochemistry methods like SDS-PAGE and LC-MS to ensure validation for research areas from oncology to neurology. For more details, visit https://www.creative-biolabs.com/bsab/.
